8:33 AM ET
8-K
Clinical Trial Data
First Tracks Biotherapeutics Clinical Trial Data
First Tracks Biotherapeutics announced positive topline data from the first Phase 1b cohort of its drug candidate ANB033 for the treatment of Celiac Disease. The company also updated its corporate investor presentation to reflect these clinical developments.